TILsOV
Phase NA Terminated
36 enrolled
AcceleRET-Lung
Phase 3 Terminated
223 enrolled 18 charts
A Study of PHN-010 in Patients With Advanced Solid Tumors
Phase 1 Terminated
26 enrolled
Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Phase 1 Terminated
18 enrolled 19 charts
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
Phase 1 Terminated
36 enrolled 7 charts
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
Phase 2 Terminated
18 enrolled
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
Phase 1/2 Terminated
52 enrolled 33 charts
CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Phase 2 Terminated
24 enrolled 18 charts
IntenSify
Phase 1 Terminated
6 enrolled
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
Phase NA Terminated
700 enrolled
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
Phase 3 Terminated
608 enrolled
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Phase 2 Terminated
13 enrolled 36 charts
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
Phase 1 Terminated
177 enrolled
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Phase 1 Terminated
103 enrolled
Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
Phase NA Terminated
12 enrolled 15 charts
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
Phase 1/2 Terminated
12 enrolled 8 charts
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
Phase 1/2 Terminated
79 enrolled
Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary
Phase 2 Terminated
14 enrolled 17 charts
GEOMETRY-E
Phase 3 Terminated
6 enrolled 20 charts
NBE-002 in Patients With Advanced Solid Tumors
Phase 1/2 Terminated
12 enrolled
CANOPY-2
Phase 3 Terminated
245 enrolled 29 charts
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
Phase 1 Terminated
20 enrolled
STARRS
Phase 2 Terminated
45 enrolled 12 charts
Safety Study of AMG 228 to Treat Solid Tumors
Phase 1 Terminated
30 enrolled
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
Phase 1 Terminated
49 enrolled
Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma
Phase 3 Terminated
130 enrolled
Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma
Phase 3 Terminated
84 enrolled
CHIPNOL
Phase NA Terminated
9 enrolled
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
Phase NA Terminated
10 enrolled 11 charts
Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy
Phase 2 Terminated
8 enrolled
Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
Phase 2 Terminated
2 enrolled 9 charts
TRAP
Phase 1 Terminated
85 enrolled
Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
Phase 1/2 Terminated
24 enrolled 12 charts
Auto TAG
Phase 1 Terminated
46 enrolled
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Phase 1/2 Terminated
23 enrolled 10 charts
UF-STO-LUNG-002
Phase 1/2 Terminated
3 enrolled 8 charts
FamGaCan
Phase NA Terminated
79 enrolled
Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Phase 3 Terminated
37 enrolled 11 charts
A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer
Phase 1 Terminated
14 enrolled
Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
Phase 1 Terminated
1 enrolled
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Phase 2 Terminated
11 enrolled
PARAGON
Phase 1/2 Terminated
4 enrolled 5 charts
Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
Phase 2 Terminated
15 enrolled
Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer
Phase 2 Terminated
17 enrolled
HER3-Lung
Phase 3 Terminated
145 enrolled 20 charts
NEOMETRE
Phase 2 Terminated
3 enrolled
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Phase 1/2 Terminated
29 enrolled 13 charts
Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 1 Terminated
1 enrolled
NRR
Phase 2 Terminated
3 enrolled 9 charts
Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer
Phase 1 Terminated
12 enrolled